Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 30, 2022 - Issue 5
Submit an article Journal homepage
166
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Multiple Evanescent White Dot Syndrome Following Medigen Vaccine Biologics Corporation COVID-19 Vaccination

Keng-Sheng LinOphthalmology Department, Taipei City Hospital, Taipei, TaiwanView further author information
, M.D. &
Ming-Hung HsiehOphthalmology Department, Taipei City Hospital, Taipei, TaiwanCorrespondence[email protected]
View further author information
, M.D.
Pages 1278-1281 | Received 21 Oct 2021, Accepted 31 Mar 2022, Published online: 20 Apr 2022

References

  • Yang JS, Chen CL, Hu YZ, Zeng R. Multiple evanescent white dot syndrome following rabies vaccination: a case report. BMC Ophthalmol. 2018;18(1):312. doi:10.1186/s12886-018-0968-y.
  • Abou-Samra A, Tarabishy AB. Multiple evanescent white dot syndrome following intradermal influenza vaccination. Ocul Immunol Inflamm. 2019;27(4):528–530. doi:10.1080/09273948.2017.1423334.
  • Ng CC, Jumper JM, Cunningham ET Jr. Multiple evanescent white dot syndrome following influenza immunization - A multimodal imaging study. Am J Ophthalmol Case Rep. 2020;19:100845. doi:10.1016/j.ajoc.2020.100845.
  • Fine L, Fine A, Cunningham ET Jr. Multiple evanescent white dot syndrome following hepatitis a vaccination. Arch Ophthalmol. 2001;119(12):1856–1858. doi:10.1001/archopht.119.12.1870.
  • Stangos A, Zaninetti M, Petropoulos I, Baglivo E, Pournaras C. Multiple evanescent white dot syndrome following simultaneous hepatitis-A and yellow fever vaccination. Ocul Immunol Inflamm. 2006;14(5):301–304. doi:10.1080/09273940600932311.
  • Baglivo E, Safran AB, Borruat FX. Multiple evanescent white dot syndrome after hepatitis B vaccine. Am J Ophthalmol. 1996;122(3):431–432. doi:10.1016/s0002-9394(14)72074-4.
  • Ogino K, Kishi S, Yoshimura N. Multiple evanescent white dot syndrome after human papillomavirus vaccination. Case Rep Ophthalmol. 2014;5(1):38–43. doi:10.1159/000358870.
  • Rabinovitch T, Ben-Arie-Weintrob Y, Hareuveni-Blum T, et al. UVEITIS AFTER THE BNT162b2 mRNA VACCINATION AGAINST SARS-CoV-2 INFECTION: a possible association. Retina. 2021;41(12):2462–2471. doi:10.1097/iae.0000000000003277.
  • McGill COVID19 Vaccine Tracker Team. COVID19 Vaccine Tracker. 2021; Available from: https://covid19.trackvaccines.org/vaccines/approved/#vaccine-list. Accessed December 11, 2021
  • Medigen Vaccine Biologics. Medigen Vaccine Biologics Corporation. 2017; Available from: https://www.medigenvac.com/public/en. Accessed December 11, 2021,
  • Hsieh SM, Liu WD, Huang YS, et al. Safety and immunogenicity of a recombinant stabilized prefusion SARS-CoV-2 spike protein vaccine (MVC-COV1901) adjuvanted with CpG 1018 and aluminum hydroxide in healthy adults: a phase 1, dose-escalation study. EClinicalMedicine. 2021;38:100989. doi:10.1016/j.eclinm.2021.100989.
  • Medigen Vaccine Biologics Corporation. MVC COVID-19 Vaccine. 2021, July 30; Available from: https://www.medigenvac.com/public/covid19/%E9%AB%98%E7%AB%AF(Medigen)COVID-19%E7%96%AB%E8%8B%97%E4%B8%AD%E6%96%87%E8%AA%AA%E6%98%8E%E6%9B%B8_(1100730%E7%89%88).pdf. Accessed October 10, 2021,
  • Jampol LM, Becker KG. White spot syndromes of the retina: a hypothesis based on the common genetic hypothesis of autoimmune/inflammatory disease. Am J Ophthalmol. 2003;135(3):376–379. doi:10.1016/s0002-9394(02)02088-3.
  • Watad A, Quaresma M, Brown S, et al. Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld’s syndrome) - An update. Lupus. 2017;26(7):675–681. doi:10.1177/0961203316686406.
  • Cunningham ET Jr., Moorthy RS. Vaccine-Associated posterior uveitis. Retina. 2020;40(4):595–598. doi:10.1097/iae.0000000000002816.
  • Tavallali A, Yannuzzi LA. MEWDS, common cold of the retina. J Ophthalmic Vis Res. 2017;12(2):132–134. doi:10.4103/jovr.jovr_241_16.
  • Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–245. doi:10.1038/clpt.1981.154.
  • Oosterhuis I, Zweers P, Rümke H, Muller-Hansma A, van Puijenbroek Ep. A tailor-made approach for causality assessment for ADR reports on drugs and vaccines. Pharmacoepidemiol Drug Saf. 2019;28(4):544–550. doi:10.1002/pds.4637.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.